Stephanie Worton

Stephanie Worton is an Academic Clinical Lecturer in Obstetrics at the University of Manchester's Maternal and Fetal Health Research Centre, part of the Division of Developmental Biology & Medicine (L5). She holds a PhD (2019), MRes (2009), and MBChB (2009) from the University of Manchester, funded by an MRC/RCOG Clinical Research Training Fellowship. Her research focuses on maternal vascular physiology, particularly hypertensive disorders in pregnancy and the kynurenine pathway's role in preeclampsia.

Education:

• Doctor of Philosophy, University of Manchester (20 Dec 2019)
• Master of Research, University of Manchester (1 Jul 2009)
• Bachelor of Medicine and Surgery, University of Manchester (1 Jul 2009)

Research Interests: Maternal vascular dysfunction mechanisms, novel treatments for preeclampsia, and small artery physiology. Her work aligns with Sustainable Development Goals targeting health and well-being.

Key Projects:

• Maternal & Fetal Health Research Centre (2018–2035), investigating placenta biology and fetal growth.
• Tommy's 2024–2025 Annual Budget (2024), supporting clinical and translational research.

Awards:

• MRC/RCOG Clinical Research Training Fellowship (PhD funding)

Grants & Supervision: Supervised one PhD thesis on kynurenine pathway manipulation and contributed to multi-institutional research collaborations. Active in clinical trial design (e.g., CHERRY trial).

Labs/Teams: Core member of the Maternal and Fetal Health Research Centre, collaborating with experts in placental biology and obstetrics.